These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1656 related articles for article (PubMed ID: 8490924)

  • 1. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by Clark level and Breslow thickness.
    Morton DL; Davtyan DG; Wanek LA; Foshag LJ; Cochran AJ
    Cancer; 1993 Jun; 71(11):3737-43. PubMed ID: 8490924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
    Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
    Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
    Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
    Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.
    Balch CM; Murad TM; Soong SJ; Ingalls AL; Halpern NB; Maddox WA
    Ann Surg; 1978 Dec; 188(6):732-42. PubMed ID: 736651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion: Use of the combined microstage technique (Clark-Breslow).
    Wanebo HJ; Fortner JG; Woodruff J; MacLean B; Binkowski E
    Ann Surg; 1975 Sep; 182(3):302-15. PubMed ID: 1164058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interobserver variation in the histopathologic reporting of key prognostic parameters, particularly clark level, affects pathologic staging of primary cutaneous melanoma.
    Murali R; Hughes MT; Fitzgerald P; Thompson JF; Scolyer RA
    Ann Surg; 2009 Apr; 249(4):641-7. PubMed ID: 19300224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive cutaneous malignant melanoma in Sweden, 1990-1999. A prospective, population-based study of survival and prognostic factors.
    Lindholm C; Andersson R; Dufmats M; Hansson J; Ingvar C; Möller T; Sjödin H; Stierner U; Wagenius G;
    Cancer; 2004 Nov; 101(9):2067-78. PubMed ID: 15372475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
    Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
    Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy in thick malignant melanoma: a 10-year single unit experience.
    Fairbairn NG; Orfaniotis G; Butterworth M
    J Plast Reconstr Aesthet Surg; 2012 Oct; 65(10):1396-402. PubMed ID: 22552263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breslow thickness, clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients.
    Munsch C; Lauwers-Cances V; Lamant L; Gentil C; Rochaix P; Garrido I; Lopez R; Chevreau C; Paul C; Meyer N
    Dermatology; 2014; 229(3):183-9. PubMed ID: 25171688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Thickness and Modified Clark Level in Canine Cutaneous Melanocytic Tumors.
    Silvestri S; Porcellato I; Mechelli L; Menchetti L; Rapastella S; Brachelente C
    Vet Pathol; 2019 Mar; 56(2):180-188. PubMed ID: 30244658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIT receptor is expressed in more than 50% of early-stage malignant melanoma: a retrospective study of 261 patients.
    Janku F; Novotny J; Julis I; Julisova I; Pecen L; Tomancova V; Kocmanova G; Krasna L; Krajsova I; Stork J; Petruzelka L
    Melanoma Res; 2005 Aug; 15(4):251-6. PubMed ID: 16034302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.
    Büttner P; Garbe C; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2499-2506. PubMed ID: 7736394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
    Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
    Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in patients with localized primary cutaneous melanoma.
    Mervic L
    Acta Dermatovenerol Alp Pannonica Adriat; 2012; 21(2):27-31. PubMed ID: 23000937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stage I malignant melanoma of the skin. Prognostic value of thickness and level (author's transl)].
    Palangié A; Lassau F; Moreau T; Noury-Duperrat G; Cottenot F
    Nouv Presse Med; 1981 Jun; 10(28):2337-41. PubMed ID: 7267338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using a continuous transformation of the Breslow thickness for prognosis in cutaneous melanoma.
    Vollmer RT; Seigler HF
    Am J Clin Pathol; 2001 Feb; 115(2):205-12. PubMed ID: 11211608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.
    Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
    Ann Surg; 1982 Dec; 196(6):677-84. PubMed ID: 7149819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 83.